Clickbait Science Exposed! Debunking the Mainstream Media's War on Cannabis

About this episode

The episode critiques the flawed science used by mainstream media against cannabis and highlights evidence supporting legalization's benefits.

Blunt Business tears apart the "bunk" science being weaponized by mainstream outlets like Reuters and The Guardian. By interrogating the raw data behind a widely cited Lancet Psychiatry study, the program exposes a collection of massive research failures—including tiny sample sizes, high risks of researcher bias, and a reliance on pharmaceutical synthetics that bear no resemblance to what consumers actually use. We call out the "misinformation machine" funded by Big Pharma and shifts the focus to the real story: new evidence linking legalization to crime reduction and the definitive countdown to Virginia’s retail market launch in 2027. Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy

Topics covered

• cannabis legalization
• mainstream media
• research failures
• crime reduction
• pharmaceuticals
• misinformation

Keywords

• cannabis
• mainstream media
• research bias
• legalization
• crime reduction
• pharmaceuticals
• Lancet Psychiatry
• Big Pharma
• Virginia retail market

Mentioned in this episode

Organizations: Reuters, The Guardian, Lancet Psychiatry, Big Pharma

Places: Virginia

More episodes of Blunt Business

• Kazmira Therapeutics and the Future of CBD Medicine · June 10, 2026 · 28 min
• The Hemp Lifeline: States Open Cannabis Gateways as Federal Lawsuit Targets MSOs · June 3, 2026 · 23 min
• Federal Rescheduling and the BUILD Act: Capitol Hill’s Shift on Cannabis Reform · May 27, 2026 · 25 min
• Georgia Expands Medical Access and D.C. Beats Cannabis Lawsuit · May 20, 2026 · 19 min
• $15 Billion Refund? Navigating Retroactive 280E Relief · May 13, 2026 · 25 min
• Can Las Vegas Cash In on the Cannabis Reclassification? · May 6, 2026 · 31 min